quercetin-3-o-gentiobioside and Obesity

quercetin-3-o-gentiobioside has been researched along with Obesity* in 1 studies

Other Studies

1 other study(ies) available for quercetin-3-o-gentiobioside and Obesity

ArticleYear
Extract of okra lowers blood glucose and serum lipids in high-fat diet-induced obese C57BL/6 mice.
    The Journal of nutritional biochemistry, 2014, Volume: 25, Issue:7

    Okra is an important tropical vegetable and source of dietary medicine. Here, we assayed the effects of an ethanol extract of okra (EO) and its major flavonoids isoquercitrin and quercetin 3-O-gentiobioside on metabolic disorders in high-fat diet-induced obese mouse. We found that treatment with EO, isoquercitrin and quercetin 3-O-gentiobioside reduced blood glucose and serum insulin levels and improved glucose tolerance in obese mice. Meanwhile, serum triglyceride levels and liver morphology in the mice were significantly ameliorated by EO and isoquercitrin treatment. Total cholesterol levels in isoquercitrin and quercetin 3-O-gentiobioside treated mice were also reduced. We also found that EO inhibited the expression of nuclear receptor transcription factor PPARĪ³, which is an important regulator of lipid and glucose homeostasis. Furthermore, we determined that EO and quercetin 3-O-gentiobioside have antioxidant activity in vitro. Our results indicate that okra may serve as a dietary therapy for hyperglycemia and hypertriglyceridemia.

    Topics: Abelmoschus; Animals; Blood Glucose; Diet, High-Fat; Disaccharides; Female; Insulin; Mice, Inbred C57BL; Mice, Obese; Obesity; Plant Extracts; PPAR gamma; Quercetin

2014